March 3, 2008 8:00AM Eastern Daylight Time
Azopharma Product Development Group Acquires Analytical Development Corporation in Colorado Springs, CO
MIRAMAR, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) is pleased to announce the acquisition of Analytical Development Corporation (ADC), a bioanalytical laboratory located in Colorado Springs, CO., which will operate under the ADMEquant Bioanalytical Services name. ADC was founded in 1971 as a contract research organization providing quality bioanalytical services to the pharmaceutical and biotechnology industries.
The ADMEquant facility occupies 17,000 square feet of laboratory and office space, including 7,500 cubic feet of temperature-monitored freezer/refrigerator storage. The staff is comprised of professionals averaging over 20 years of experience in analytical chemistry with expertise in ADME and metabolism studies. According to Phil Meeks, Azopharma Chief Executive Officer, “The knowledge and experience at ADMEquant adds a lot to the Azopharma Product Development Group. Their experience supporting preclinical and clinical studies lifts the level of service and capabilities we can provide to our clients.”
ADMEquant’s analytical capabilities include:
· Proprietary Methods
· All Matrices & Species
· LC/MS/MS, HPLC, GC & LSC
· GLP, GCP & cGMP Compliant
|
· Methods Development
· Methods Validation
· Preclinical Support
· Clinical Support
|
This latest acquisition enhances the extensive product development services from The Azopharma Product Development Group and provides a dedicated lab to support its preclinical and clinical projects. When asked about the acquisition Phil Meeks stated, “With last year’s acquisition of AniClin Preclinical Services and this January’s acquisition of AvivoClin Clinical Services, we wanted to add a world class bioanalytical laboratory. Acquiring ADMEquant gives us access to a large library of methods and additional instrumentation capacity to support large scale early and late stage programs.”
Azopharma Product Development Group Includes:
- Azopharma Contract Pharmaceutical Services - Integrated product development and CTM manufacturing for all dosage forms.
- ApiCross Drug Delivery Technologies - Proprietary drug delivery platforms to solve difficult molecular challenges.
- Cyanta Analytical Laboratories - Analytical chemistry and inhalation services from development to quality control testing.
- AniClin Preclinical Services - Preclinical services in support of early product development.
- IQsynthesis - Synthetic chemistry services from discovery to clinical API supplies including large scale API synthesis.
- AvivoClin Clinical Services - Human clinical pharmacology services for Phase I/II/III clinical trials.
- ADMEquant Bioanalytical Services - Bioanaytical research analysis of pharmaceutical compounds in all matrices.
About Azopharma
Azopharma Product Development Group is FDA registered, DEA approved and client audited on a regular basis. Azopharma’s mission is to help our customers turn Ideas Into Cures™. In product development, it comes down to the right people, their commitment and application of experience. Partnering with Azopharma provides customers with the confidence of assured success. We welcome visits to our facility in Miramar, FL as well as our other sites to conduct audits or meet with our pharmaceutical scientists to outline a study that meets your specific needs. Contact us at development@azopharma.com or 954-433-7480.
Contact
Phil Meeks, CEO
Azopharma Product Development Group
10320 USA Today Way
Miramar FL 33025
Phone: 954-433-7480
www.azopdogroup.com